23 C
New York
Thursday, June 11, 2026

Tag: vector

/C O R R E C T I O N — The Galien Foundation/

In the news release, The Galien Foundation Announces 2026 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical...

Zilliz Launches Vector Lakebase, Extending the World’s Most Adopted Vector Database into a Unified Data Platform for AI

Available now in public preview on Zilliz Cloud, Vector Lakebase keeps production vector search at its core and adds shared lake-native storage and on-demand...

RVL Strength, The World’s Most Advanced Weightlifting Power Rack Upgrade, Launches in North America

SEATTLE, June 10, 2026 /PRNewswire/ -- RVL Strength, a Seattle-based fitness equipment company, today officially launches its flagship product, RVL Wings. This single and...

ARRAS MINERALS DRILLS 935.9M GRADING 0.71% CUEQ FROM SURFACE INCLUDING 214.9M GRADING 1.42% CUEQ STARTING AT 162.1M DEPTH FROM THE BEREZSKI NORTH PORPHYRY TARGET,...

TSX-V: ARK / OTCQB: ARRKFVANCOUVER, BC, June 9, 2026 /CNW/ - Arras Minerals Corp. (TSXV: ARK) (OTCQB: ARRKF) ("Arras" or "Arras Minerals" or "the Company")...

Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference

Fangzhou showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health.

Visionary Advances on Multiple Fronts at Pt. Leamington: Phase 2 Drilling Permits Submitted; Prospecting Permits Filed for ~30,000 Ha Regional Land Package; Field Personnel...

HighlightsExploration Permit Applications filed for:Phase 2 Diamond Drilling at the Pt. Leamington VMS Deposit targeting deposit resource upgrade / expansion of the emerging Kraken...

Visionary Advances on Multiple Fronts at Pt. Leamington: Phase 2 Drilling Permits Submitted; Prospecting Permits Filed for ~30,000 Ha Regional Land Package; Field Personnel...

HighlightsExploration Permit Applications filed for:Phase 2 Diamond Drilling at the Pt. Leamington VMS Deposit targeting deposit resource upgrade / expansion of the emerging Kraken...

Orion Innovation and Amrita University Launch Applied GenAI Elective Program to Prepare Students for AI-Driven Careers

Industry-academia collaboration brings hands-on AI learning and real-world technology exposure to students across three campusesCOIMBATORE, India, June 4, 2026 /PRNewswire/ -- Orion Innovation ("Orion"), a...

NetFoundry Launches Enterprise-Class MCP and LLM Gateways, Bringing Zero Trust to AI Deployments

Identity-First Reachability™ eliminates the attack surface that AI agents, MCP servers, and LLMs create — addressing the #1 breach vector in enterprise security todayCHARLOTTE,...

Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy

MEQUON, Wis., June 2, 2026 /PRNewswire/ -- Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors...

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on August 12, 2025, the compensation committee of the Company’s board of directors granted three new non-executive employees 58,900 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

- A word from our sponsors -

spot_img
HomeTagsVector